JP2024517642A5 - - Google Patents
Info
- Publication number
- JP2024517642A5 JP2024517642A5 JP2023564119A JP2023564119A JP2024517642A5 JP 2024517642 A5 JP2024517642 A5 JP 2024517642A5 JP 2023564119 A JP2023564119 A JP 2023564119A JP 2023564119 A JP2023564119 A JP 2023564119A JP 2024517642 A5 JP2024517642 A5 JP 2024517642A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- viral protein
- modified
- parent
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2021/060273 | 2021-04-20 | ||
| EP2021060273 | 2021-04-20 | ||
| PCT/EP2022/060417 WO2022223617A1 (en) | 2021-04-20 | 2022-04-20 | Virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517642A JP2024517642A (ja) | 2024-04-23 |
| JP2024517642A5 true JP2024517642A5 (https=) | 2025-04-25 |
Family
ID=81579467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564119A Pending JP2024517642A (ja) | 2021-04-20 | 2022-04-20 | ウイルスワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240383947A1 (https=) |
| EP (1) | EP4326317A1 (https=) |
| JP (1) | JP2024517642A (https=) |
| KR (1) | KR20240009419A (https=) |
| CN (1) | CN117750974A (https=) |
| AU (1) | AU2022260466A1 (https=) |
| BR (1) | BR112023021654A2 (https=) |
| CA (1) | CA3215771A1 (https=) |
| IL (1) | IL307762A (https=) |
| MX (1) | MX2023012368A (https=) |
| WO (1) | WO2022223617A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| CN117153245B (zh) * | 2023-10-18 | 2024-03-19 | 无锡市疾病预防控制中心 | 预测新型冠状病毒S蛋白RBD区域与hACE2受体相互作用的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| EP1900753B1 (en) | 2002-11-08 | 2017-08-09 | Ablynx N.V. | Method of administering therapeutic polypeptides, and polypeptides therefor |
| HUE027902T2 (en) | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
| US20070269422A1 (en) | 2006-05-17 | 2007-11-22 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
| CN101511868B (zh) | 2006-07-24 | 2013-03-06 | 比奥雷克西斯制药公司 | 毒蜥外泌肽融合蛋白 |
| AU2007293614A1 (en) | 2006-09-08 | 2008-03-13 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
| WO2009083804A2 (en) | 2007-12-27 | 2009-07-09 | Novartis Ag | Improved fibronectin-based binding molecules and their use |
| EA201001734A1 (ru) | 2008-05-02 | 2011-10-31 | Новартис Аг | Улучшенные связывающие молекулы на основе фибронектина и их применение |
| EP2281579A1 (en) | 2009-08-05 | 2011-02-09 | BioNTech AG | Vaccine composition comprising 5'-Cap modified RNA |
| EP2493871B1 (en) | 2009-10-30 | 2014-09-03 | Domain Therapeutics | Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| EP2556087A1 (en) | 2010-04-09 | 2013-02-13 | Novozymes Biopharma DK A/S | Albumin derivatives and variants |
| EP2558491B1 (en) | 2010-04-13 | 2018-07-04 | Bristol-Myers Squibb Company | Fibronectin based scaffold domain proteins that bind pcsk9 |
| EP2758436B1 (en) | 2011-09-23 | 2019-06-12 | Universität Stuttgart | Serum half-life extension using immunoglobulin binding domains |
| EP2780364A2 (en) | 2011-11-18 | 2014-09-24 | Eleven Biotherapeutics, Inc. | Proteins with improved half-life and other properties |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| WO2016005004A1 (en) | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
-
2022
- 2022-04-20 BR BR112023021654A patent/BR112023021654A2/pt not_active Application Discontinuation
- 2022-04-20 WO PCT/EP2022/060417 patent/WO2022223617A1/en not_active Ceased
- 2022-04-20 JP JP2023564119A patent/JP2024517642A/ja active Pending
- 2022-04-20 EP EP22720733.9A patent/EP4326317A1/en active Pending
- 2022-04-20 IL IL307762A patent/IL307762A/en unknown
- 2022-04-20 CN CN202280043287.9A patent/CN117750974A/zh active Pending
- 2022-04-20 US US18/287,608 patent/US20240383947A1/en active Pending
- 2022-04-20 AU AU2022260466A patent/AU2022260466A1/en active Pending
- 2022-04-20 CA CA3215771A patent/CA3215771A1/en active Pending
- 2022-04-20 KR KR1020237039881A patent/KR20240009419A/ko active Pending
- 2022-04-20 MX MX2023012368A patent/MX2023012368A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024517642A5 (https=) | ||
| Li et al. | SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates | |
| BR0312935A (pt) | Partìcula semelhante a vìrus, muteìna, vetores para produzir a referida partìcula e proteìna recombinante, composição, processo para produção de fileira ordena e repetitva de antìgeno, molécula de ácido nucléico, célula hospedeira, método para produção da referida partìcula e uso da composição de vacina | |
| BR9907691A (pt) | Derivados de antìgeno associado a tumor da famìlia mage, e sequências de ácido nucléico codificando os mesmos, usados para a preparação de proteìnas de fusão e de composições para vacinação | |
| WO2015080973A1 (en) | A novel sars immunogenic composition | |
| US20110150920A1 (en) | Allergy Vaccines Containing Hybrid Polypeptides | |
| CN105431535A (zh) | 疟疾疫苗 | |
| CN1867355A (zh) | 包含诱导粘膜免疫的佐剂的新型疫苗 | |
| JP2014507146A5 (https=) | ||
| Bassel-Duby et al. | Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer | |
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| IL307762A (en) | Vaccine against viruses | |
| US20220054625A1 (en) | Immunogenic composition | |
| WO2024055273A1 (zh) | 一种狂犬病mRNA疫苗、其制备及应用 | |
| JP6863966B2 (ja) | 標的ポリペプチドを提示するためのポリペプチド担体及びその使用 | |
| EP4640833A1 (en) | Monkeypox virus nucleic acid vaccine and use thereof | |
| JP2024512575A (ja) | 弱毒化されたレオウイルスベースのワクチン組成物及びその用途 | |
| CN119039453A (zh) | 一种痘病毒单链融合免疫原、包含其的免疫原性组合物及其应用 | |
| KR101614344B1 (ko) | 합성 펩티드를 함유하는 항원약물 비이클과 이것을 사용하는 점막 백신 | |
| AU2016201589B2 (en) | Peptide adjuvants | |
| US20240261389A1 (en) | Amino acids, nucleotides and vectors expressing the same and uses thereof in preventing sarbecovirus infection | |
| EP4317176A1 (en) | Attenuated reovirus-based vaccine composition and use thereof | |
| US20080026008A1 (en) | Bacteriophage DNA vaccine vector | |
| EP4415748A1 (en) | Multiepitope self-assembled nanoparticle vaccine platform (msn-vaccine platform) and uses there of | |
| JP2005082581A (ja) | 分泌型ＩｇＡ抗体誘導剤 |